Moleculin Biotech receives Nasdaq notice over $1 minimum bid
Nasdaq Staff determined Moleculin Biotech failed to meet the $1.00 minimum bid price requirement for 30 consecutive business days under Listing Rule 5550(a)(2).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.